ACTRN12616001017415已完成1 期
A Phase 1 Study to Determine the Relative Bioavailability of ACH-0144471 After Administration of a Tablet or Softgel Capsule Versus a Liquid Filled Capsule in Healthy Volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy adult male or female subjects. Females must be of non-child bearing potential. Healthy is defined as having no clinically relevant abnormalities identified by a detailed medical history, physical exam, blood pressure and pulse rate measurements, 12-lead ECG, and clinical laboratory tests.
- •Healthy volunteers must have a normal weight defined as minimum body weight of 50 kg and a BMI of 18 to 30kg/m2.
排除标准
- •If participants have any of the following criteria, they will be excluded from the study.
- •- Smokers and have a clinically significant disease or allergy,
- •- An active infection
- •- Consume more than 21 alcoholic drinks/week.
- •- Evidence of drug abuse or have taken prescription medications (systemic and topical) within 14 days prior to dosing.
研究者
相似试验
已完成
1 期
A Phase 1 Study of Two PRN1008 Tablet Formulations and the impact of Midazolam and Famotidine on PRN1008 in Healthy SubjectsACTRN12618000249257Principia Biopharma Inc14
已完成
不适用
A Study to Evaluate the Relative Bioavailability and Effect of Food on Two Formulations of the MK-3682A Fixed-Dose Combination Tablets (MK-3682/MK-5172/MK-8742, 300 mg/ 100 mg/50 mg) in Healthy Adult Subjects.HCVHepatitis C virus10047438NL-OMON41736Merck Sharp & Dohme (MSD)22
已完成
不适用
A study to evaluate the relative bioavailability and effect of food on two 450mg MK-3682 Fixed-Dose Combination Formulations (MK-3682 /MK-5172 /MK-8408)10047438Hepatitis CNL-OMON41967Merck Sharp & Dohme (MSD)24
已完成
不适用
A study to evaluate the relative bioavailability and effect of food on MK-3682B Fixed-Dose Combination Tablet (MK-3682/MK-8408/MK-5172)10047438Hepatitis CNL-OMON41831QPS Netherlands B.V.22
已完成
1 期
A phase I study to compare the bioavailability and pharmacokinetics of fentanyl after administration of a single dose of a Fentanyl MDTS and a Durogesic 25 patch in paiPainOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000526673Acrux DDS Pty Ltd6